New York, NY -- (SBWIRE) -- 01/06/2014 -- PennyStockChronicle covers the breadth of the markets, from NASDAQ, NYSE, AMEX, ETF, Penny Stocks, Emerging Markets, activities at the Fed and more. PennyStockChronicle brings you the most vibrant coverage of following stocks: Glu Mobile Inc (NASDAQ:GLUU), Harmony Gold Mining Co. (ADR) (NYSE:HMY), Penn Virginia Corporation (NYSE:PVA), Generex Biotechnology Corporation (OTCMKTS:GNBT)
Glu Mobile Inc (NASDAQ:GLUU) showed a volume of 2.38 million shares by the end of last trade whereas the average volume of the stock remained 2.50 million shares. The stock opened the session at $3.95 but then moved to $3.90. Glu Mobile Inc. (Glu) designs, markets and sells mobile games. The Company has developed and published a portfolio of action/adventure and casual games designed to appeal to a cross section of the users of smartphones and tablet devices who purchase its games through direct-to-consumer digital storefronts, as well as users of feature phones served by wireless carriers and other distributors.
Is GLUU a Solid Investment at These Levels? Read This Report For Details
Harmony Gold Mining Co. (ADR) (NYSE:HMY) opened the session at $2.63and closed the session at $2.61. The stock showed a positive performance of 1.95% in previous trading session. Traded with volume of 2.36 million shares in the prior session and the average volume of the stock remained 2.84 million shares. Harmony Gold Mining Company Limited (Harmony) is engaged in conducting underground and surface gold mining and related activities, including exploration, processing and smelting. During the fiscal year ended June 30, 2012 (fiscal 2012), its mining operations reported total proven and probable reserves of 52.9 million ounces (including gold equivalent ounces),
For How Long HMY will fight for Profitability? Read This Trend Analysis report
Penn Virginia Corporation (NYSE:PVA) opened the session at $9.19 and closed the session at $9.12. The stock showed a negative performance of -0.98% in previous trading session. Traded with volume of 2.33 million shares in the prior session and the average volume of the stock remained 2.54 million shares. The beta of the stock remained 1.83. Generex Biotechnology Corporation is a Canada-based Company, which develops drug delivery systems and technologies for the treatment of diabetes. The Company has developed a proprietary platform technology for the delivery of drugs into the human body through the oral cavity. Its buccal insulin spray product, Generex Oral-lyn is in Phase III clinical trials at several sites around the world.
Why Should Investors Buy PVA After the Recent Fall? Just Go Here and Find Out
Generex Biotechnology Corporation (OTCMKTS:GNBT) the stock advanced 6.67% and finished the session at $0.0320. Traded with volume of 2.34 million shares in the prior session and the average volume of the stock remained 1.89 million shares. The beta of the stock remained 2.12. Penn Virginia Corporation (Penn Virginia) is an independent oil and gas company engaged primarily in the exploration, development and production of oil, natural gas liquids (NGL) and natural gas in various domestic onshore regions of the United States, including Texas, the Mid-Continent and Mississippi. As of December 31, 2012, the Company's proved reserves were approximately 113 million barrels of oil per day ,
Will GNBT Continue To Move Higher? Find Out Here
Penny Stock Chronicle is comprised of a team of vetted penny stock traders who’ve been trading since 2008 & have developed the skills needed to trade for consistent profits.
PLEASE NOTE WELL: The employees of PennyStockChronicle.com are not registered as Investment Advisors in any jurisdiction whatsoever. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. Investing in “penny stocks” is highly speculative.
Verify all claims and do your own due diligence on all securities. PennyStockChronicle.com profiles are not a solicitation or recommendation to buy, sell or hold securities. PennyStockChronicle.com is not offering securities for sale. Neither PennyStockChronicle.com nor its owners, operators, affiliates or anyone disseminating information on its behalf is registered as an Investment Advisor under any federal or state law and none of the information provided by PennyStockChronicle.com, its owners, operators, affiliates or anyone disseminating information on its behalf should be construed as investment advice or investment recommendations. PennyStockChronicle.com does not recommend that the securities profiled should be purchased, sold or held.
Read Full Disclaimer at: http://pennystockchronicle.com/disclaimer
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)